Eisai,Teikoku Seiyaku in pact to market Haojishi in China

Haojishi is an anti-inflammatory analgesic poultice that contains glycol salicylate and menthol as two of its main ingredients.

Available in China as a prescription medication, the product comes in two types; one that generates a hot sensation and another that creates a cool sensation.

The marketing rights for Haojishi are being transferred to Eisai‘s Chinese subsidiary Eisai China as the current contract between Teikoku Seiyaku and a local Chinese distributor is scheduled to expire at the end of December this year.

Teikoku Seiyaku will supply the finished product to Eisai China for distribution.